|
| Evolution | P-value | |
| Remission | Failed | ||
| Age | |||
| Under 40 | 10 (100%) | 0 (0%) | 0.534 NS |
| Over 40 years | 12 (80%) | 3 (20%) | |
| Sex | |||
| Male | 4 (80%) | 1 (20%) | 1 NS |
| Female | 16 (80%) | 4 (20%) | |
| Baseline thyroid function | |||
| Hyperthyroidism | 16 (84%) | 3 (16%) | 0.838 NS |
| Euthyroïdie | 4 (66.7%) | 2 (33.3%) | |
| Therapeutic activity | |||
| Less than 15mCi | 12 (80%) | 5 (20%) | 0.042* |
| 16mCi and more | 8 (100%) | 0 (0%) | |
| Disease progression time | |||
| Less than 18 months | 1 (50%) | 1 (50%) | 0.659 NS |
| More than 18 months | 19 (79%) | 4 (21%) | |